Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

GALTGALT
Showing 8 of 29 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in GALECTIN THERAPEUTICS INC

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds 116,424 shares of GALT (GALECTIN THERAPEUTICS INC), worth $540,207 as of 2026-Q2. The position was increased (+287.9% shares). GALT represents 0.0% of CHARLES SCHWAB INVESTMENT MANAGEMENT INC's portfolio.

Current Value

$540,207

Current Shares

116,424

Total Value Change

+$361,256

Total Shares Change

+51,351

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
116,424
+287.9%
$540,2070.0%$4.64
39
2026-Q1
Increased
30,010
+0.1%
$83,7280.0%$2.98
15
2025-Q4
Decreased
29,985
-33.4%
$124,7380.0%$4.08
0
2025-Q3
New
44,989
-
$190,5280.0%$4.22
35
2025-Q2
Exited
0
-100.0%
$00.0%$2.33
0
2025-Q1
Decreased
22,913
-64.8%
$27,9540.0%$1.52
0
2024-Q4
Unchanged
65,073
0.0%
$83,9440.0%$1.10
0
2024-Q3
Unchanged
65,073
0.0%
$178,9510.0%$2.71
0

Other major holders of GALT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, OSAIC HOLDINGS, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used